Ursprung des Netzwerks ersten Grades von Stuart Garret
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
RezGen5 Ltd.
 RezGen5 Ltd. Pharmaceuticals: MajorHealth Technology RezGen5 Ltd. operates as a biopharmaceutical company, which focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with ageing, including metabolic diseases such as Type 2 Diabetes, Alzheimer's and cardiovascular diseases. The company was founded by Stuart Garret on June 15, 2012 and is headquartered in Hamilton, Bermuda.
1
| Private Company | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Stuart Garret
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| OPTIGENEX INC. | Biotechnology | Corporate Officer/Principal | |
| University of Lund | College/University | Corporate Officer/Principal | |
| Campamed, Inc. | Corporate Officer/Principal | ||
| Deep South Partners LLC | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 5 |
| Schweden | 2 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Operativ
| Corporate Officer/Principal | 5 |
| Chief Tech/Sci/R&D Officer | 1 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Ronald W. Pero | 6 |
- Börse
- Insiders
- Stuart Garret
- Unternehmensverbindungen
